Table 5 Cox regression analysis for MACE of CMD patients

Age

1.024 (0.996–1.052)

1.027 (0.996–1.059)

Male

1.221 (0.737–2.025)

BMI

0.999 (0.925–1.079)

Heart rate

1.003 (0.982–1.025)

Atrial fibrillation

2.443 (0.975–6.116)

1.256 (0.469–3.362)

Smoking

1.128 (0.621–2.049)

Hypertension

1.367 (0.809–2.311)

PCI performed

1.181 (0.719–1.938)

Diabetes

1.828 (1.115–2.999)

1.287 (0.761–2.176)

CKD

1.926 (0.947–3.916)

0.873 (0.288–2.645)

CAD

1.369 (0.825–2.270)

1- vessel disease

0.995 (0.557–1.778)

2- vessel disease

1.174 (0.647–2.128)

3- vessel disease

1.654 (0.816–3.353)

TyG index

1.506 (1.085–2.090)

-

TyG Tertiles

T1

Reference

Reference

T2

1.357 (0.689–2.674)

1.595 (0.785–3.241)

T3

2.157 (1.156–4.025)

2.132 (1.066–4.261)

TG

1.100 (0.960–1.261)

FBG

1.141 (1.047–1.244)

-

HbA1c

1.161 (0.946–1.425)

CRP

0.990 (0.952–1.031)

Serum creatinine

1.012 (1.001–1.024)

1.010 (0.991–1.028)

TC

1.054 (0.837–1.329)

LDL-C

1.039 (0.794–1.359)

LVEF

0.914 (0.884–0.944)

0.925 (0.890–0.961)

caFFR

0.011 (1 × 10^–6-85.756)

caIMR

0.998 (0.975–1.021)

Aspirin

0.695 (0.416–1.162)

Clopidogrel

1.606 (0.968–2.665)

1.341 (0.786–2.287)

Statin

1.243 (0.566–2.729)

ACEI/ARB

1.521 (0.926–2.497)

0.997 (0.562–1.771)

Beta blocker

0.804 (0.488–1.325)

CCB

1.048 (0.633–1.735)